Comerica Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$44.3M Sell
1,779,844
-51,538
-3% -$1.3M 0.18% 106
2025
Q3
$46.7M Sell
1,831,382
-48,571
-3% -$1.2M 0.18% 106
2025
Q2
$45.6M Buy
1,879,953
+6,742
+0.4% +$157K 0.18% 109
2025
Q1
$47.5M Buy
1,873,211
+42,053
+2% +$1.1M 0.2% 96
2024
Q4
$48.6M Sell
1,831,158
-176,740
-9% -$4.79M 0.2% 97
2024
Q3
$58.1M Sell
2,007,898
-19,935
-1% -$582K 0.23% 77
2024
Q2
$56.7M Buy
2,027,833
+45,456
+2% +$1.25M 0.24% 75
2024
Q1
$55M Sell
1,982,377
-25,705
-1% -$713K 0.24% 80
2023
Q4
$57.8M Sell
2,008,082
-102,459
-5% -$3.1M 0.27% 72
2023
Q3
$70M Buy
2,110,541
+630,708
+43% +$22.3M 0.36% 47
2023
Q2
$740 Buy
+1,479,833
New +$57.6M 0.08% 26
2022
Q4
$62.6M Buy
1,359,482
+9,153
+0.7% +$439K 0.49% 31
2022
Q3
$61.5M Buy
1,350,329
+17,923
+1% +$871K 0.52% 27
2022
Q2
$68.4M Sell
1,332,406
-41,556
-3% -$2.12M 0.56% 24
2022
Q1
$68.4M Sell
1,373,962
-3,721
-0.3% -$193K 0.5% 28
2021
Q4
$72.4M Sell
1,377,683
-48,458
-3% -$2.4M 0.53% 24
2021
Q3
$61.6M Sell
1,426,141
-296,809
-17% -$13.1M 0.37% 45
2021
Q2
$84.1M Sell
1,722,950
-32,686
-2% -$1.27M 0.5% 23
2021
Q1
$67.9M Sell
1,755,636
-22,571
-1% -$801K 0.4% 34
2020
Q4
$65M Sell
1,778,207
-138,073
-7% -$5.06M 0.41% 34
2020
Q3
$69.4M Sell
1,916,280
-7,687
-0.4% -$270K 0.5% 24
2020
Q2
$70.4M Buy
1,923,967
+60,331
+3% +$2.05M 0.54% 24
2020
Q1
$66.1M Buy
1,863,636
+5,672
+0.3% +$193K 0.61% 22
2019
Q4
$65.3M Sell
1,857,964
-47,389
-2% -$1.69M 0.5% 32
2019
Q3
$65.8M Buy
1,905,353
+12,829
+0.7% +$467K 0.52% 28
2019
Q2
$76.7M Sell
1,892,524
-90,504
-5% -$3.59M 0.61% 20
2019
Q1
$80.4M Sell
1,983,028
-170,182
-8% -$6.82M 0.65% 20
2018
Q4
$83.3M Sell
2,153,210
-93,227
-4% -$3.87M 0.71% 13
2018
Q3
$94M Sell
2,246,437
-350,404
-13% -$13.5M 0.76% 11
2018
Q2
$92.8M Sell
2,596,841
-80,121
-3% -$2.74M 0.65% 18
2018
Q1
$92.8M Sell
2,676,962
-41,043
-2% -$1.41M 0.66% 16
2017
Q4
$95.2M Sell
2,718,005
-51,817
-2% -$1.77M 0.63% 21
2017
Q3
$92.4M Buy
2,769,822
+524,887
+23% +$16.9M 0.67% 17
2017
Q2
$71M Buy
2,244,935
+49,995
+2% +$1.58M 0.53% 29
2017
Q1
$70.5M Sell
2,194,940
-115,504
-5% -$3.64M 0.54% 27
2016
Q4
$71.3M Buy
2,310,444
+12,442
+0.5% +$380K 0.56% 25
2016
Q3
$73.4M Buy
2,298,002
+60,326
+3% +$2.02M 0.63% 23
2016
Q2
$74.5M Sell
2,237,676
-111,135
-5% -$3.55M 0.64% 19
2016
Q1
$72.4M Sell
2,348,811
-1,576
-0.1% -$45K 0.65% 20
2015
Q4
$69.1M Sell
2,350,387
-1,980
-0.1% -$62.3K 0.68% 18
2015
Q3
$70.1M Sell
2,352,367
-2,421,678
-51% -$77.6M 0.66% 18
2015
Q2
$152M Buy
4,774,045
+2,279,938
+91% +$74.3M 0.65% 16
2015
Q1
$82.3M Sell
2,494,107
-2,778,456
-53% -$88.3M 0.7% 14
2014
Q4
$156M Buy
5,272,563
+2,548,380
+94% +$73.1M 0.67% 18
2014
Q3
$76.4M Sell
2,724,183
-130,165
-5% -$3.65M 0.67% 15
2014
Q2
$80.4M Sell
2,854,348
-639,700
-18% -$18.2M 0.68% 12
2014
Q1
$106M Sell
3,494,048
-26,163
-0.7% -$780K 0.82% 10
2013
Q4
$102M Sell
3,520,211
-1,430,652
-29% -$41.6M 0.79% 11
2013
Q3
$135M Buy
4,950,863
+18,376
+0.4% +$500K 0.94% 7
2013
Q2
$131M Buy
+4,932,487
New +$136M 1.07% 8

Other funds holding PFE

Comerica Bank's PFE Position: Q4 2025 in Review

Comerica Bank reduced its Pfizer (PFE) stake by 2.8% in Q4 2025, selling an estimated $1.3M and leaving 1,779,844 shares worth $44.3M. The position accounts for 0.18% of the portfolio, ranked #106.

Comerica Bank first reported a position in PFE in Q2 2013 and has held it in 50 quarters since. The position peaked at $156M in Q4 2014. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Comerica Bank held 1,779,844 shares of Pfizer worth $44.3M as of Q4 2025.
  • Comerica Bank sold 51,538 Pfizer shares in Q4 2025, an estimated $1.3M.
  • Pfizer made up 0.18% of Comerica Bank's portfolio in Q4 2025, its #106 holding.
  • Comerica Bank first reported a position in Pfizer in Q2 2013 and has held it in 50 quarters since.
  • Comerica Bank's Pfizer position peaked at $156M in Q4 2014.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.